Novel substance DC 113 and production thereof

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435119, 514410, C07D48704, A61K 3140

Patent

active

051010380

ABSTRACT:
A novel fermentation product, DC113, represented by the formula ##STR1## which has antimicrobial and antitumor activities.

REFERENCES:
patent: 4169888 (1979-10-01), Hanka et al.
patent: 4400518 (1983-08-01), Wierenga
patent: 4413132 (1983-11-01), Wierenga
patent: 4423228 (1983-12-01), Wierenga
patent: 4423229 (1983-11-01), Wierenga
patent: 4423230 (1983-12-01), Wierenga
Adv. Enzyme Regulation, Wierenga, et al. "Antitumor Activity and Biochemistry of Novel Analogs of the Antibiotic, CC-1065", vol. 22, p. 141 (1986).
J. Medicinal Chemistry, Warpehoski, M. A. et al., "Stereoelectronic Factors Influencing the Biological Activity and DNA Interaction of Synthetic Antitumor Agents Modeled on CC-1065," vol. 31, No. 3, p. 590 (1988).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Novel substance DC 113 and production thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel substance DC 113 and production thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel substance DC 113 and production thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2260875

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.